All news
Act4Biosimilars: The Action Plan and Deep Dive Report for Europe are Now Live!
20 November 2023Act4Biosimilars is a global initiative that aims to increase patient access to biologics by facilitating greater Approvability, Accessibility, Acce...
3rd International Symposium on Pancreatic Cancer
28 October 2023On 16-18 October, French researchers from the AFRCP (Association Française pour la Recherche sur le Cancer du Pancreas) organised the ‘Pancr...
EuropaColon Portugal Launched Support Line for Carers
27 October 2023Europacolon Portugal and Merck Portugal have launched a psychological support line for informal carers.
...
DiCE Participants Complete Patient Expert Training
27 October 2023We are thrilled to announce that two participants from Digestive Cancers Europe (DiCE) completed the EUPATI Patient Expert Training Programme in Pr...
New Expert Advisor on CRC Screening
27 October 2023We are delighted to welcome Dr. Carlo Senore as our new advisor for colorectal cancer screening. Dr. Senore brings a wealth of expertise to our org...
Economist Impact: World Cancer Series Europe
24 September 2023On 20 September, the Belgian delegation of the DiCE Team attended the Economist Impact’s World Cancer Series: Europe in Brussels, proudly sup...
Do You Dare to Think Differently about Cancer?
24 September 2023The Cancer Grand Challenges mission is “Uniting the World’s brightest minds against cancer’s toughest challenges”. Founded by CRUK (Cancer ...
Promising Approach in Treating Rectal Cancer: Rethinking Radiation Before Surgery
23 September 2023Radiation combined with chemotherapy, also known as chemoradiotherapy, is routinely given to people with rectal cancer whose tumours can be removed...
Understanding Metastatic Colorectal Cancer: A Call to Awareness on World Metastatic Colorectal Cancer Day
21 September 2023World Metastatic Colorectal Cancer (mCRC) Day stands as a symbol of hope and determination in the face of the challenges posed by this advanced sta...
Predictive Values of Blood-based RNA Signature for the FOLFIRINOX/FOLFOX Response in Advanced Pancreatic Cancer
18 July 2023Presently, no widely recognised or established biomarkers are specifically designed to predict the effectiveness of FOLFIRINOX/FOLFOX (chemotherape...
